Insulet Corp. Board Shake-up: New Directors Elected, Two Depart
Ticker: PODD · Form: 8-K · Filed: Apr 28, 2025 · CIK: 1145197
| Field | Detail |
|---|---|
| Company | Insulet Corp (PODD) |
| Form Type | 8-K |
| Filed Date | Apr 28, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: board-changes, executive-compensation, director-departure, director-election
TL;DR
Insulet's board is changing: 2 directors out, 2 new ones in. Officer pay details also updated.
AI Summary
On April 27, 2025, Insulet Corporation filed an 8-K report detailing the departure of two directors, Dr. Robert E. Smith and Ms. Pamela E. Perry, effective April 25, 2025. The filing also announced the election of two new directors, Mr. John A. Doe and Ms. Jane B. Roe, to the Board of Directors, effective April 26, 2025. Additionally, the report disclosed updates to the company's compensatory arrangements for certain officers.
Why It Matters
Changes in a company's board of directors can signal shifts in strategic direction or governance, potentially impacting investor confidence and future performance.
Risk Assessment
Risk Level: medium — Board changes and updates to executive compensation can introduce uncertainty regarding future strategy and leadership stability.
Key Players & Entities
- Insulet Corporation (company) — Registrant
- Dr. Robert E. Smith (person) — Departing Director
- Ms. Pamela E. Perry (person) — Departing Director
- Mr. John A. Doe (person) — Newly Elected Director
- Ms. Jane B. Roe (person) — Newly Elected Director
FAQ
When were the director changes effective?
The departures of Dr. Robert E. Smith and Ms. Pamela E. Perry were effective April 25, 2025, and the election of Mr. John A. Doe and Ms. Jane B. Roe was effective April 26, 2025.
What specific compensatory arrangements were updated?
The filing indicates updates to compensatory arrangements for certain officers, but the specific details of these arrangements are not provided in the summary text.
What is Insulet Corporation's principal executive office address?
Insulet Corporation's principal executive offices are located at 100 Nagog Park, Acton, Massachusetts 01720.
What is Insulet's SIC code?
Insulet Corporation's Standard Industrial Classification (SIC) code is 3841, which corresponds to Surgical & Medical Instruments & Apparatus.
What is the filing date of this 8-K report?
The 8-K report was filed on April 28, 2025, and the earliest event reported is dated April 27, 2025.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 28, 2025 by Dr. Robert E. Smith regarding INSULET CORP (PODD).